SGLT2 抑制剂和急性损伤
Yuki Nakao1,2, Makiko Mori1,2, Yutaro Mori1,2
1Divisions of Renal Medicine and Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
概括
-葡萄糖共载体-2 抑制剂 (SGLT2i) 除了降低血糖之外,还能为和心脏提供保护. 这些药物可以显著降低患者急性损伤 (AKI) 的风险.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 心脏病学 心脏病学
- 内分泌学 在内分泌学.
背景情况:
- -葡萄糖共载体-2抑制剂 (SGLT2i) 主要是2型糖尿病的降葡萄糖剂.
- SGLT2i已经证明了意想不到的心脏保护和脏保护益处.
- 这些脏和心脏影响背后的机制需要进一步阐明.
研究的目的:
- 审查SGLT2抑制剂对脏的生理影响.
- 关于SGLT2抑制剂对急性损伤 (AKI) 的影响的临床数据.
- 将分子机制与有关SGLT2抑制剂使用的临床发现相结合.
主要方法:
- 对脏中SGLT2抑制剂作用的生理数据的综述.
- 对SGLT2抑制剂和AKI现有临床研究的分析.
- 将分子途径研究与临床观察相结合.
主要成果:
- SGLT2 抑制剂通过抑制近道管的再吸收来降低血糖.
- 临床数据表明,SGLT2抑制剂对脏和心脏提供长期的保护作用.
- 新出现的证据表明,SGLT2抑制剂可能会降低AKI的发生率.
结论:
- SGLT2 抑制剂对脏和心脏健康具有有益的影响,超出了血糖控制.
- SGLT2 抑制剂显示出降低急性损伤 (AKI) 风险的潜力.
- 需要进一步研究SGLT2抑制剂介导的AKI保护的分子机制.
相关概念视频
Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
Acute Kidney Injury I: Introduction
76
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
76
Acute Kidney Injury II: Pathophysiology
81
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
81
Acute Kidney Injury V: Interprofessional Care
45
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
45
Acute Kidney Injury III: Clinical Manifestations
94
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
94
Acute Kidney Injury VI: Nursing Management
61
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
61


